Heron Therapeutics | HRTX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.88B 133M 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
Eisai JPY 1.2T 219.32B 2026-06
Emergent BioSolutions USD 125M 51M 2023-12
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 23.11B 12.19B 2026-06
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
Merck USD 317.37B 20.27B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pacira USD 998M 83M 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Veracyte USD 4.69B 2.12B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06